ENMAR CONSULTING LIMITED

ENMAR CONSULTING LIMITED

Statement of Financial Position

As at 31 January 2026

	2026 £		2025 £
Fixed assets		9,857		13,142
Current assets	475,957		441,553
Creditors: amount falling due within one year	(78,398)		(69,690)
Net current assets/(liabilities)		397,559		371,863
Total assets less current liabilities		407,416		385,005
Net assets/(liabilities)		407,416		385,005


Capital and reserves		407,416		385,005

Notes to the Accounts

Statutory Information

Enmar Consulting Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number 08364927, registration address Ground Floor Flat, 199 Redland Road, Bristol, BS6 6YS, England.

The presentation currency is £ sterling.

1.	Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

2.	Average number of employees Average number of employees during the year was 1 (2025: 1).

3.	Director's Loan At the yearend, the director's account was overdrawn by £55,741. At 31 January 2024, the balance on the loan was £33,793.

Director's Responsibilities:

For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:

---------------------------------------------

Nicholas Rutherford
Director

Date approved: 27 October 2026